Kaposi's sarcoma epidemiology and demographics: Difference between revisions

	Kaposi's sarcoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Kaposi's sarcoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiograph and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Kaposi's sarcoma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Kaposi's sarcoma epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Kaposi's sarcoma epidemiology and demographics
CDC on Kaposi's sarcoma epidemiology and demographics
Kaposi's sarcoma epidemiology and demographics in the news
Blogs on Kaposi's sarcoma epidemiology and demographics
Directions to Hospitals Treating Kaposi's sarcoma
Risk calculators and risk factors for Kaposi's sarcoma epidemiology and demographics

← Older edit Newer edit →

VisualWikitext

Revision as of 22:36, 11 June 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

In the United States, the age-adjusted prevalence of Kaposi sarcoma is 0.0081% in 2011.^[1]

Epidemiology and Demographics

Prevalence

In the United States, the age-adjusted prevalence of Kaposi sarcoma is 8.1 per 100,000 in 2011.^[1]

Incidence

In 2011, the age-adjusted incidence of Kaposi sarcoma was 0.64 per 100,000 persons in the United States.^[1]
Shown below is an image depicting the incidence of Kaposi sarcoma versus all types of cancers in the United States from 1975 to 2011.

Age

While the overall age-adjusted incidence of Kaposi sarcoma in the United States between 2007 and 2011 is 0.5 per 100,000, the age-adjusted incidence of Kaposi sarcoma by age category is:^[1]
- Under 65 years: 0.5 per 100,000
- 65 and over: 1 per 100,000

Gender

In the United States, the age-adjusted prevalence of Kaposi sarcoma by gender in 2011 is:^[1]
- In males: 16 per 100,000
- In females: 0.6 per 100,000

Race

Shown below is a table depicting the age-adjusted prevalence of Kaposi sarcoma by race in 2011 in the United States.^[1]

	All Races	White	Black	Asian/Pacific Islander	Hispanic
Age-adjusted prevalence	8.1 per 100,000	8 per 100,000	12.4 per 100,000	2 per 100,000	11.1 per 100,000

References

↑ ^1.0 ^1.1 ^1.2 ^1.3 ^1.4 ^1.5 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

Template:WH Template:WS

[SEER-1] 1.0 ^1.1 ^1.2 ^1.3 ^1.4 ^1.5 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

[1]

@@ Line 9: / Line 9: @@
 ===Prevalence===
-* In the United States, the age-adjusted [[prevalence]] of Kaposi sarcoma is 0.0081% in 2011.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
+* In the United States, the age-adjusted [[prevalence]] of Kaposi sarcoma is 8.1 per 100,000 in 2011.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
 ===Incidence===
@@ Line 26: / Line 26: @@
 * In the United States, the age-adjusted prevalence of Kaposi sarcoma by gender in 2011 is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
-** In males: 0.016%
+** In males: 16 per 100,000
-** In females: 0.0006%
+** In females: 0.6 per 100,000
 ===Race===
@@ Line 37: / Line 37: @@
 |style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''All Races''' ||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''White''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Black''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Asian/Pacific Islander'''  || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Hispanic'''
 |-
-| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Age-adjusted prevalence'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.0081% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.0080% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 0.0124%||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.002% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.0111
+| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Age-adjusted prevalence'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |8.1 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |8 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 12.4 per 100,000||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |11.1 per 100,000
 |}